Agilon Health (NYSE:AGL) Trading Up 12.6% – Time to Buy?

Shares of Agilon Health, Inc. (NYSE:AGL) shot up 12.6% during trading on Thursday . The stock traded as high as $93.79 and last traded at $93.1160. 49,253 shares traded hands during mid-day trading, a decline of 86% from the average session volume of 357,793 shares. The stock had previously closed at $82.70.

Analysts Set New Price Targets

AGL has been the topic of a number of recent analyst reports. Jefferies Financial Group raised shares of Agilon Health from a “hold” rating to a “buy” rating and increased their price target for the stock from $27.50 to $48.00 in a research note on Thursday, May 7th. Weiss Ratings downgraded Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. TD Cowen reaffirmed a “hold” rating and set a $55.00 price target (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $72.00 price target (up from $37.50) on shares of Agilon Health in a research note on Friday, May 8th. Finally, JPMorgan Chase & Co. downgraded shares of Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 target price for the company. in a research report on Monday, May 4th. Five investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, Agilon Health presently has an average rating of “Hold” and a consensus price target of $58.73.

Agilon Health Stock Up 17.3%

The firm has a market cap of $1.62 billion, a P/E ratio of -4.48 and a beta of 3.02. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The business’s fifty day moving average price is $44.12 and its two-hundred day moving average price is $26.41.

Agilon Health (NYSE:AGL) last announced its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. The company had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative net margin of 6.09% and a negative return on equity of 146.03%. As a group, equities research analysts anticipate that Agilon Health, Inc. will post -3.5 EPS for the current year.

Hedge Funds Weigh In On Agilon Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Wealthcare Advisory Partners LLC bought a new position in Agilon Health in the 3rd quarter valued at approximately $26,000. LPL Financial LLC grew its position in shares of Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares during the period. Krilogy Financial LLC bought a new position in shares of Agilon Health during the 4th quarter valued at approximately $34,000. CIBC Bancorp USA Inc. purchased a new stake in Agilon Health during the third quarter valued at about $34,000. Finally, Merit Financial Group LLC purchased a new position in shares of Agilon Health in the fourth quarter valued at $35,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.